당뇨병성 케톤산증 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "당뇨병성 케톤산증" in Korean language version.

refsWebsite

Global rank Korean rank

24doi.org

2^nd place

3^rd place

24nih.gov

4^th place

7semanticscholar.org

11^th place

310^th place

7web.archive.org

1^st place

2books.google.com

3^rd place

9^th place

2archive.org

6^th place

18^th place

2diabetesjournals.org

low place

6,992^nd place

1handle.net

102^nd place

307^th place

1abcd.care

low place

1aappublications.org

3,763^rd place

1,221^st place

1nice.org.uk

3,258^th place

1,025^th place

1bsped.org.uk

low place

aappublications.org

pediatrics.aappublications.org

Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, 외. (February 2004). “European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents”. 《Pediatrics》 113 (2): e133–e140. doi:10.1542/peds.113.2.e133. PMID 14754983. 2009년 9월 12일에 원본 문서에서 보존된 문서.

abcd.care

Joint British Diabetes Societies Inpatient Care Group (June 2021). “The Management of Diabetic Ketoacidosis in Adults”. Association of British Clinical Diabetologists. 2021년 12월 9일에 원본 문서에서 보존된 문서. 2021년 8월 10일에 확인함.

archive.org

Marcdante KJ, Kliegman R (2015). 〈Diabetes Melitus〉. Marcdante KJ, Kliegman R, Nelson WD. 《Nelson Essentials of Pediatrics》 7판. 573–576쪽. ISBN 978-1-4557-5980-4.
Dillon ES, Riggs HE, Dyer WW (1936). “Cerebral lesions in uncomplicated fatal diabetic acidosis”. 《American Journal of the Medical Sciences》 192 (3): 360–365. doi:10.1097/00000441-193609000-00007. S2CID 72917358.

books.google.com

Ferri FF (2010). 《Ferri's Differential Diagnosis: A Practical Guide to the Differential Diagnosis of Symptoms, Signs, and Clinical Disorders》 (영어). Elsevier Health Sciences. 146쪽. ISBN 978-0323076999. 2017년 9월 8일에 원본 문서에서 보존된 문서.
Elzouki AY, Harfi HA, Nazer H, Oh W, Stapleton FB, Whitley RJ (2011). 《Textbook of Clinical Pediatrics》 (영어). Springer Science & Business Media. 2567쪽. ISBN 9783642022012.

bsped.org.uk

Edge J (May 2009). “BSPED Recommended DKA Guidelines 2009” (PDF). British Society for Paediatric Endocrinology and Diabetes. 2011년 10월 27일에 원본 문서 (PDF)에서 보존된 문서. 2009년 7월 12일에 확인함.

diabetesjournals.org

care.diabetesjournals.org

Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (December 2006). “Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association”. 《Diabetes Care》 29 (12): 2739–2748. doi:10.2337/dc06-9916. PMID 17130218. 2010년 3월 27일에 원본 문서에서 보존된 문서.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, 외. (January 2005). “Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association”. 《Diabetes Care》 28 (1): 186–212. doi:10.2337/diacare.28.1.186. PMID 15616254. 2016년 4월 19일에 원본 문서에서 보존된 문서.

doi.org

dx.doi.org

Misra S, Oliver NS (October 2015). “Diabetic ketoacidosis in adults”. 《BMJ》 351: h5660. doi:10.1136/bmj.h5660. hdl:10044/1/41091. PMID 26510442. S2CID 38872958.
Bialo SR, Agrawal S, Boney CM, Quintos JB (February 2015). “Rare complications of pediatric diabetic ketoacidosis”. 《World Journal of Diabetes》 6 (1): 167–174. doi:10.4239/wjd.v6.i1.167. PMC 4317308. PMID 25685287.
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (July 2009). “Hyperglycemic crises in adult patients with diabetes”. 《Diabetes Care》 32 (7): 1335–1343. doi:10.2337/dc09-9032. PMC 2699725. PMID 19564476.
Maletkovic J, Drexler A (December 2013). “Diabetic ketoacidosis and hyperglycemic hyperosmolar state”. 《Endocrinology and Metabolism Clinics of North America》 42 (4): 677–695. doi:10.1016/j.ecl.2013.07.001. PMID 24286946.
Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N (May 2006). “Overview of the diagnosis and management of diabetic ketoacidosis”. 《The American Journal of the Medical Sciences》 331 (5): 243–251. doi:10.1097/00000441-200605000-00002. PMID 16702793.
Umpierrez GE, Smiley D, Kitabchi AE (March 2006). “Narrative review: ketosis-prone type 2 diabetes mellitus”. 《Annals of Internal Medicine》 144 (5): 350–357. doi:10.7326/0003-4819-144-5-200603070-00011. PMID 16520476. S2CID 33296818.
Goldenberg RM, Berard LD, Cheng AY, Gilbert JD, Verma S, Woo VC, Yale JF (December 2016). “SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis”. 《Clinical Therapeutics》 38 (12): 2654–2664.e1. doi:10.1016/j.clinthera.2016.11.002. PMID 28003053.
Perry RJ, Rabin-Court A, Song JD, Cardone RL, Wang Y, Kibbey RG, Shulman GI (February 2019). “Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats”. 《Nature Communications》 10 (1): 548. doi:10.1038/s41467-019-08466-w. PMC 6358621. PMID 30710078.
Milder DA, Milder TY, Kam PC (August 2018). “Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations”. 《Anaesthesia》 73 (8): 1008–1018. doi:10.1111/anae.14251. PMID 29529345.
Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, 외. (June 2019). “International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors”. 《Diabetes Care》 42 (6): 1147–1154. doi:10.2337/dc18-2316. PMC 6973545. PMID 30728224. As a general guideline, SGLT-inhibitor therapy should not be used in patients using lowcarbohydrate or ketogenic diets as, anecdotally, they seem to be at increased risk of adverse ketosis effects
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (December 2006). “Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association”. 《Diabetes Care》 29 (12): 2739–2748. doi:10.2337/dc06-9916. PMID 17130218. 2010년 3월 27일에 원본 문서에서 보존된 문서.
Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, 외. (February 2004). “European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents”. 《Pediatrics》 113 (2): e133–e140. doi:10.1542/peds.113.2.e133. PMID 14754983. 2009년 9월 12일에 원본 문서에서 보존된 문서.
Brown TB (March 2004). “Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?”. 《Emergency Medicine Journal》 21 (2): 141–144. doi:10.1136/emj.2002.001578. PMC 1726262. PMID 14988335.
Klocker AA, Phelan H, Twigg SM, Craig ME (July 2013). “Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review”. 《Diabetic Medicine》 30 (7): 818–824. doi:10.1111/dme.12136. PMID 23330615. S2CID 22070325.
Misra S, Oliver NS (January 2015). “Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis”. 《Diabetic Medicine》 32 (1): 14–23. doi:10.1111/dme.12604. PMID 25307274. S2CID 11923923.
Jayashree M, Williams V, Iyer R (2019). “Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives”. 《Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy》 12: 2355–2361. doi:10.2147/DMSO.S194944. PMC 6858801. PMID 31814748.
Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA (January 2016). “Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD011281. doi:10.1002/14651858.CD011281.pub2. PMC 8829395. PMID 26798030.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, 외. (January 2005). “Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association”. 《Diabetes Care》 28 (1): 186–212. doi:10.2337/diacare.28.1.186. PMID 15616254. 2016년 4월 19일에 원본 문서에서 보존된 문서.
Lindner LM, Rathmann W, Rosenbauer J (January 2018). “Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review”. 《Diabetic Medicine》 35 (1): 12–32. doi:10.1111/dme.13519. PMID 28945942. S2CID 24297858.
Patel A, Singh D, Bhatt P, Thakkar B, Akingbola OA, Srivastav SK (September 2016). “Incidence, Trends, and Outcomes of Cerebral Edema Among Children With Diabetic Ketoacidosis in the United States”. 《Clinical Pediatrics》 55 (10): 943–951. doi:10.1177/0009922815617975. PMID 26603587. S2CID 25624176.
Dreschfeld J (August 1886). “The Bradshawe Lecture on Diabetic Coma”. 《British Medical Journal》 2 (1338): 358–363. doi:10.1136/bmj.2.1338.358. PMC 2256374. PMID 20751675.
Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB (May 2008). “Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state”. 《The Journal of Clinical Endocrinology and Metabolism》 93 (5): 1541–1552. doi:10.1210/jc.2007-2577. PMC 2386681. PMID 18270259.
Dillon ES, Riggs HE, Dyer WW (1936). “Cerebral lesions in uncomplicated fatal diabetic acidosis”. 《American Journal of the Medical Sciences》 192 (3): 360–365. doi:10.1097/00000441-193609000-00007. S2CID 72917358.
Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP (February 1987). “Maturity-onset diabetes of youth in black Americans”. 《The New England Journal of Medicine》 316 (6): 285–291. doi:10.1056/NEJM198702053160601. PMID 3543673.

handle.net

hdl.handle.net

Misra S, Oliver NS (October 2015). “Diabetic ketoacidosis in adults”. 《BMJ》 351: h5660. doi:10.1136/bmj.h5660. hdl:10044/1/41091. PMID 26510442. S2CID 38872958.

nice.org.uk

“Type 1 diabetes in adults: diagnosis and management”. National Institute for Health and Care Excellence. August 2015. 2016년 8월 9일에 원본 문서에서 보존된 문서. 2016년 2월 10일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Misra S, Oliver NS (October 2015). “Diabetic ketoacidosis in adults”. 《BMJ》 351: h5660. doi:10.1136/bmj.h5660. hdl:10044/1/41091. PMID 26510442. S2CID 38872958.
Bialo SR, Agrawal S, Boney CM, Quintos JB (February 2015). “Rare complications of pediatric diabetic ketoacidosis”. 《World Journal of Diabetes》 6 (1): 167–174. doi:10.4239/wjd.v6.i1.167. PMC 4317308. PMID 25685287.
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (July 2009). “Hyperglycemic crises in adult patients with diabetes”. 《Diabetes Care》 32 (7): 1335–1343. doi:10.2337/dc09-9032. PMC 2699725. PMID 19564476.
Maletkovic J, Drexler A (December 2013). “Diabetic ketoacidosis and hyperglycemic hyperosmolar state”. 《Endocrinology and Metabolism Clinics of North America》 42 (4): 677–695. doi:10.1016/j.ecl.2013.07.001. PMID 24286946.
Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N (May 2006). “Overview of the diagnosis and management of diabetic ketoacidosis”. 《The American Journal of the Medical Sciences》 331 (5): 243–251. doi:10.1097/00000441-200605000-00002. PMID 16702793.
Glaser N (June 2006). “New perspectives on the pathogenesis of cerebral edema complicating diabetic ketoacidosis in children”. 《Pediatric Endocrinology Reviews》 3 (4): 379–386. PMID 16816806.
Umpierrez GE, Smiley D, Kitabchi AE (March 2006). “Narrative review: ketosis-prone type 2 diabetes mellitus”. 《Annals of Internal Medicine》 144 (5): 350–357. doi:10.7326/0003-4819-144-5-200603070-00011. PMID 16520476. S2CID 33296818.
Goldenberg RM, Berard LD, Cheng AY, Gilbert JD, Verma S, Woo VC, Yale JF (December 2016). “SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis”. 《Clinical Therapeutics》 38 (12): 2654–2664.e1. doi:10.1016/j.clinthera.2016.11.002. PMID 28003053.
Perry RJ, Rabin-Court A, Song JD, Cardone RL, Wang Y, Kibbey RG, Shulman GI (February 2019). “Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats”. 《Nature Communications》 10 (1): 548. doi:10.1038/s41467-019-08466-w. PMC 6358621. PMID 30710078.
Milder DA, Milder TY, Kam PC (August 2018). “Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations”. 《Anaesthesia》 73 (8): 1008–1018. doi:10.1111/anae.14251. PMID 29529345.
Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, 외. (June 2019). “International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors”. 《Diabetes Care》 42 (6): 1147–1154. doi:10.2337/dc18-2316. PMC 6973545. PMID 30728224. As a general guideline, SGLT-inhibitor therapy should not be used in patients using lowcarbohydrate or ketogenic diets as, anecdotally, they seem to be at increased risk of adverse ketosis effects
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (December 2006). “Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association”. 《Diabetes Care》 29 (12): 2739–2748. doi:10.2337/dc06-9916. PMID 17130218. 2010년 3월 27일에 원본 문서에서 보존된 문서.
Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, 외. (February 2004). “European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents”. 《Pediatrics》 113 (2): e133–e140. doi:10.1542/peds.113.2.e133. PMID 14754983. 2009년 9월 12일에 원본 문서에서 보존된 문서.
Brown TB (March 2004). “Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?”. 《Emergency Medicine Journal》 21 (2): 141–144. doi:10.1136/emj.2002.001578. PMC 1726262. PMID 14988335.
Klocker AA, Phelan H, Twigg SM, Craig ME (July 2013). “Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review”. 《Diabetic Medicine》 30 (7): 818–824. doi:10.1111/dme.12136. PMID 23330615. S2CID 22070325.
Misra S, Oliver NS (January 2015). “Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis”. 《Diabetic Medicine》 32 (1): 14–23. doi:10.1111/dme.12604. PMID 25307274. S2CID 11923923.
Jayashree M, Williams V, Iyer R (2019). “Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives”. 《Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy》 12: 2355–2361. doi:10.2147/DMSO.S194944. PMC 6858801. PMID 31814748.
Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA (January 2016). “Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD011281. doi:10.1002/14651858.CD011281.pub2. PMC 8829395. PMID 26798030.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, 외. (January 2005). “Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association”. 《Diabetes Care》 28 (1): 186–212. doi:10.2337/diacare.28.1.186. PMID 15616254. 2016년 4월 19일에 원본 문서에서 보존된 문서.
Lindner LM, Rathmann W, Rosenbauer J (January 2018). “Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review”. 《Diabetic Medicine》 35 (1): 12–32. doi:10.1111/dme.13519. PMID 28945942. S2CID 24297858.
Patel A, Singh D, Bhatt P, Thakkar B, Akingbola OA, Srivastav SK (September 2016). “Incidence, Trends, and Outcomes of Cerebral Edema Among Children With Diabetic Ketoacidosis in the United States”. 《Clinical Pediatrics》 55 (10): 943–951. doi:10.1177/0009922815617975. PMID 26603587. S2CID 25624176.
Dreschfeld J (August 1886). “The Bradshawe Lecture on Diabetic Coma”. 《British Medical Journal》 2 (1338): 358–363. doi:10.1136/bmj.2.1338.358. PMC 2256374. PMID 20751675.
Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB (May 2008). “Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state”. 《The Journal of Clinical Endocrinology and Metabolism》 93 (5): 1541–1552. doi:10.1210/jc.2007-2577. PMC 2386681. PMID 18270259.
Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP (February 1987). “Maturity-onset diabetes of youth in black Americans”. 《The New England Journal of Medicine》 316 (6): 285–291. doi:10.1056/NEJM198702053160601. PMID 3543673.

semanticscholar.org

api.semanticscholar.org

Misra S, Oliver NS (October 2015). “Diabetic ketoacidosis in adults”. 《BMJ》 351: h5660. doi:10.1136/bmj.h5660. hdl:10044/1/41091. PMID 26510442. S2CID 38872958.
Umpierrez GE, Smiley D, Kitabchi AE (March 2006). “Narrative review: ketosis-prone type 2 diabetes mellitus”. 《Annals of Internal Medicine》 144 (5): 350–357. doi:10.7326/0003-4819-144-5-200603070-00011. PMID 16520476. S2CID 33296818.
Klocker AA, Phelan H, Twigg SM, Craig ME (July 2013). “Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review”. 《Diabetic Medicine》 30 (7): 818–824. doi:10.1111/dme.12136. PMID 23330615. S2CID 22070325.
Misra S, Oliver NS (January 2015). “Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis”. 《Diabetic Medicine》 32 (1): 14–23. doi:10.1111/dme.12604. PMID 25307274. S2CID 11923923.
Lindner LM, Rathmann W, Rosenbauer J (January 2018). “Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review”. 《Diabetic Medicine》 35 (1): 12–32. doi:10.1111/dme.13519. PMID 28945942. S2CID 24297858.
Patel A, Singh D, Bhatt P, Thakkar B, Akingbola OA, Srivastav SK (September 2016). “Incidence, Trends, and Outcomes of Cerebral Edema Among Children With Diabetic Ketoacidosis in the United States”. 《Clinical Pediatrics》 55 (10): 943–951. doi:10.1177/0009922815617975. PMID 26603587. S2CID 25624176.
Dillon ES, Riggs HE, Dyer WW (1936). “Cerebral lesions in uncomplicated fatal diabetic acidosis”. 《American Journal of the Medical Sciences》 192 (3): 360–365. doi:10.1097/00000441-193609000-00007. S2CID 72917358.

web.archive.org

Ferri FF (2010). 《Ferri's Differential Diagnosis: A Practical Guide to the Differential Diagnosis of Symptoms, Signs, and Clinical Disorders》 (영어). Elsevier Health Sciences. 146쪽. ISBN 978-0323076999. 2017년 9월 8일에 원본 문서에서 보존된 문서.
Joint British Diabetes Societies Inpatient Care Group (June 2021). “The Management of Diabetic Ketoacidosis in Adults”. Association of British Clinical Diabetologists. 2021년 12월 9일에 원본 문서에서 보존된 문서. 2021년 8월 10일에 확인함.
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (December 2006). “Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association”. 《Diabetes Care》 29 (12): 2739–2748. doi:10.2337/dc06-9916. PMID 17130218. 2010년 3월 27일에 원본 문서에서 보존된 문서.
Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, 외. (February 2004). “European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents”. 《Pediatrics》 113 (2): e133–e140. doi:10.1542/peds.113.2.e133. PMID 14754983. 2009년 9월 12일에 원본 문서에서 보존된 문서.
“Type 1 diabetes in adults: diagnosis and management”. National Institute for Health and Care Excellence. August 2015. 2016년 8월 9일에 원본 문서에서 보존된 문서. 2016년 2월 10일에 확인함.
Edge J (May 2009). “BSPED Recommended DKA Guidelines 2009” (PDF). British Society for Paediatric Endocrinology and Diabetes. 2011년 10월 27일에 원본 문서 (PDF)에서 보존된 문서. 2009년 7월 12일에 확인함.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, 외. (January 2005). “Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association”. 《Diabetes Care》 28 (1): 186–212. doi:10.2337/diacare.28.1.186. PMID 15616254. 2016년 4월 19일에 원본 문서에서 보존된 문서.